These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 23907394)

  • 1. Analysis of hepatitis C virus core/NS5A protein co-localization using novel cell culture systems expressing core-NS2 and NS5A of genotypes 1-7.
    Galli A; Scheel TKH; Prentoe JC; Mikkelsen LS; Gottwein JM; Bukh J
    J Gen Virol; 2013 Oct; 94(Pt 10):2221-2235. PubMed ID: 23907394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trans-complementation of an NS2 defect in a late step in hepatitis C virus (HCV) particle assembly and maturation.
    Yi M; Ma Y; Yates J; Lemon SM
    PLoS Pathog; 2009 May; 5(5):e1000403. PubMed ID: 19412343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based Recombinant.
    Mathiesen CK; Prentoe J; Meredith LW; Jensen TB; Krarup H; McKeating JA; Gottwein JM; Bukh J
    J Virol; 2015 Aug; 89(15):7758-75. PubMed ID: 25995244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutations.
    Scheel TK; Gottwein JM; Carlsen TH; Li YP; Jensen TB; Spengler U; Weis N; Bukh J
    J Virol; 2011 Mar; 85(6):2891-906. PubMed ID: 21177811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of functional differences between hepatitis C virus NS5A of genotypes 1-7 in infectious cell culture systems.
    Scheel TK; Prentoe J; Carlsen TH; Mikkelsen LS; Gottwein JM; Bukh J
    PLoS Pathog; 2012; 8(5):e1002696. PubMed ID: 22654662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and application of hepatitis C reporter viruses with genotype 1 to 7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified JFH1 NS5A.
    Gottwein JM; Jensen TB; Mathiesen CK; Meuleman P; Serre SB; Lademann JB; Ghanem L; Scheel TK; Leroux-Roels G; Bukh J
    J Virol; 2011 Sep; 85(17):8913-28. PubMed ID: 21697486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NS2 protein of hepatitis C virus interacts with structural and non-structural proteins towards virus assembly.
    Popescu CI; Callens N; Trinel D; Roingeard P; Moradpour D; Descamps V; Duverlie G; Penin F; Héliot L; Rouillé Y; Dubuisson J
    PLoS Pathog; 2011 Feb; 7(2):e1001278. PubMed ID: 21347350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A concerted action of hepatitis C virus p7 and nonstructural protein 2 regulates core localization at the endoplasmic reticulum and virus assembly.
    Boson B; Granio O; Bartenschlager R; Cosset FL
    PLoS Pathog; 2011 Jul; 7(7):e1002144. PubMed ID: 21814513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient Hepatitis C Virus Genotype 1b Core-NS5A Recombinants Permit Efficacy Testing of Protease and NS5A Inhibitors.
    Pham LV; Ramirez S; Carlsen THR; Li YP; Gottwein JM; Bukh J
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential sensitivity of 5'UTR-NS5A recombinants of hepatitis C virus genotypes 1-6 to protease and NS5A inhibitors.
    Li YP; Ramirez S; Humes D; Jensen SB; Gottwein JM; Bukh J
    Gastroenterology; 2014 Mar; 146(3):812-821.e4. PubMed ID: 24262279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell culture-adaptive mutations in hepatitis C virus promote viral production by enhancing viral replication and release.
    Wang Q; Li Y; Liu SA; Xie W; Cheng J
    World J Gastroenterol; 2018 Mar; 24(12):1299-1311. PubMed ID: 29599605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detergent-resistant membrane association of NS2 and E2 during hepatitis C virus replication.
    Shanmugam S; Saravanabalaji D; Yi M
    J Virol; 2015 Apr; 89(8):4562-74. PubMed ID: 25673706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly.
    Appel N; Zayas M; Miller S; Krijnse-Locker J; Schaller T; Friebe P; Kallis S; Engel U; Bartenschlager R
    PLoS Pathog; 2008 Mar; 4(3):e1000035. PubMed ID: 18369481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses.
    Gottwein JM; Scheel TK; Hoegh AM; Lademann JB; Eugen-Olsen J; Lisby G; Bukh J
    Gastroenterology; 2007 Nov; 133(5):1614-26. PubMed ID: 17983807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of full-length cell-culture infectious clone and subgenomic replicon for a genotype 3a isolate of hepatitis C virus.
    Chen M; Xu Y; Li N; Yin P; Zhou Q; Feng S; Wu T; Wei L; Wang H; Fu Y; Li YP
    J Gen Virol; 2021 Dec; 102(12):. PubMed ID: 34949310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell culture-adaptive mutations promote viral protein-protein interactions and morphogenesis of infectious hepatitis C virus.
    Jiang J; Luo G
    J Virol; 2012 Sep; 86(17):8987-97. PubMed ID: 22674987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: failure of homologous neutralizing-antibody treatment to control infection.
    Jensen TB; Gottwein JM; Scheel TK; Hoegh AM; Eugen-Olsen J; Bukh J
    J Infect Dis; 2008 Dec; 198(12):1756-65. PubMed ID: 19032070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylserine-specific phospholipase A1 involved in hepatitis C virus assembly through NS2 complex formation.
    Guo M; Pei R; Yang Q; Cao H; Wang Y; Wu C; Chen J; Zhou Y; Hu X; Lu M; Chen X
    J Virol; 2015 Feb; 89(4):2367-77. PubMed ID: 25505071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of infectious genotype 1b virus particles in cell culture and impairment by replication enhancing mutations.
    Pietschmann T; Zayas M; Meuleman P; Long G; Appel N; Koutsoudakis G; Kallis S; Leroux-Roels G; Lohmann V; Bartenschlager R
    PLoS Pathog; 2009 Jun; 5(6):e1000475. PubMed ID: 19521536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant HCV variants with NS5A from genotypes 1-7 have different sensitivities to an NS5A inhibitor but not interferon-α.
    Scheel TK; Gottwein JM; Mikkelsen LS; Jensen TB; Bukh J
    Gastroenterology; 2011 Mar; 140(3):1032-42. PubMed ID: 21111742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.